The purpose of this study is to determine the safety and efficacy of the use of the
combination therapy adalimumab (ADA) every other week (EOW) with methotrexate (MTX) in
suboptimal responders to ADA monotherapy.
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Site Reference ID/Investigator# 126315, Barrie L4M 6L2, Canada; Recruiting
Site Reference ID/Investigator# 126315, Principal Investigator
Site Reference ID/Investigator# 129016, Barrie L4M 7G1, Canada; Recruiting
Site Reference ID/Investigator# 129016, Principal Investigator
Site Reference ID/Investigator# 128352, Bathurst E2A 4Z9, Canada; Recruiting
Site Reference ID/Investigator# 128352, Principal Investigator
Site Reference ID/Investigator# 126518, Calgary T2G 1B1, Canada; Recruiting
Site Reference ID/Investigator# 126518, Principal Investigator
Site Reference ID/Investigator# 126317, Edmonton T5K 1X3, Canada; Recruiting
Site Reference ID/Investigator# 126317, Principal Investigator
Site Reference ID/Investigator# 129015, Edmonton T6J 5E5, Canada; Recruiting
Site Reference ID/Investigator# 129015, Principal Investigator
Site Reference ID/Investigator# 126352, Hamilton L8N 1V6, Canada; Recruiting
Site Reference ID/Investigator# 126352, Principal Investigator
Site Reference ID/Investigator# 126318, Markham L3P 1X2, Canada; Recruiting
Site Reference ID/Investigator# 126318, Principal Investigator
Site Reference ID/Investigator# 126595, Ottawa K2G 6E2, Canada; Recruiting
Site Reference ID/Investigator# 126595, Principal Investigator
Site Reference ID/Investigator# 126773, Peterborough K9J 5K2, Canada; Recruiting
Site Reference ID/Investigator# 126773, Principal Investigator
Site Reference ID/Investigator# 127634, Richmond Hill L4C 9M7, Canada; Recruiting
Site Reference ID/Investigator# 127634, Principal Investigator
Site Reference ID/Investigator# 133833, Saint-Jerome J7Z 3B8, Canada; Recruiting
Site Reference ID/Investigator# 133833, Principal Investigator
Site Reference ID/Investigator# 126802, St. John's A1A 4Y3, Canada; Recruiting
Site Reference ID/Investigator# 126802, Principal Investigator
Site Reference ID/Investigator# 126978, St. John's A1C 2H5, Canada; Recruiting
Site Reference ID/Investigator# 126978, Principal Investigator
Site Reference ID/Investigator# 126979, St. John's A1A 5E8, Canada; Recruiting
Site Reference ID/Investigator# 126979, Principal Investigator
Site Reference ID/Investigator# 128398, Sudbury P3C 1X8, Canada; Recruiting
Site Reference ID/Investigator# 128398, Principal Investigator
Site Reference ID/Investigator# 126520, Surrey V3R 6A7, Canada; Recruiting
Site Reference ID/Investigator# 126520, Principal Investigator
Site Reference ID/Investigator# 127803, Surrey V3V 0C6, Canada; Recruiting
Site Reference ID/Investigator# 127803, Principal Investigator
Site Reference ID/Investigator# 126519, Toronto M5S 3P4, Canada; Recruiting
Site Reference ID/Investigator# 126519, Principal Investigator
Site Reference ID/Investigator# 127944, Vancouver V5Z 4E8, Canada; Recruiting
Site Reference ID/Investigator# 127944, Principal Investigator
Site Reference ID/Investigator# 126351, Waterloo N2J 1C4, Canada; Recruiting
Site Reference ID/Investigator# 126351, Principal Investigator
Site Reference ID/Investigator# 126521, Westmount H3Z 2S6, Canada; Recruiting
Site Reference ID/Investigator# 126521, Principal Investigator
Site Reference ID/Investigator# 126320, Winnipeg R3C 0N2, Canada; Recruiting
Site Reference ID/Investigator# 126320, Principal Investigator